NeuStar Inc. (NYSE: NSR) has acquired Followap Inc., a UK-based provider of mobile instant messaging products in Europe and Asia, for approximately $139 million in cash. NeuStar said that it projects Followap revenue to exceed $25 million in 2007 and to more than double in 2008. Followap raised $12 million in a 2001 Series B […]
Informatica Corp. (Nasdaq: INFA) has agreed to acquire Itemfield Inc., a San Mateo, Calif.-based provider of XML-based data transformation software, for approximately $55 million in cash. Itemfield has raised around $17.5 million in total VC funding since its 2000 inception, from firms like Accel Partners, Evergreen Capital Partners, Foundation Capital and Gemini Israel. www.informatica.com www.itemfield.com
VeriSign Inc. (Nasdaq: VRSN) has agreed to acquire inCode Wireless Inc., a San Diego-based business and technology consulting firm focused on mobility solutions. The deal is valued at approximately $52 million. InCode has raised over $20 million in VC funding from firms like Sequoia Capital, Focus Ventures and inOvate Communications Group. www.verisign.com www.incodewireless.com
First Coverage Inc., a Toronto-based provider of coverage optimization software for the institutional investment community, has raised US$5 million in first-round funding. GrandBanks Capital and J.L. Albright Ventures co-led the deal. www.firstcoverage.com
Chongqing Haifu Technology Co Ltd., a Chongqing, China-based manufacturer of therapeutic ultrasound devices, has sold a 20% ownership stake to CMIA Capital Partners. No financial terms were disclosed. www.haifu.com.cn www.cmia.com
Artes Medical Inc., a San Diego-based developer of injectable aesthetic products for the dermatology and plastic surgery markets, set its proposed IPO terms to 4.6 million common shares being offered at between $12 and $14 per share. It plans to trade on the Nasdaq under ticker symbol ARTE, with Cowan & Co. and Lazard Capital […]
US BioEnergy Corp., an Inner Grove Heights, Minn.-based ethanol production company, set its proposed IPO terms to 9.375 million common shares being offered at between $15 and $17 per share. It plans to trade on the Nasdaq under ticker symbol USBE, with UBS and Piper Jaffray serving as co-lead underwriters (Credit Suisse has been dropped). […]
Asthmatx Inc., a Mountain View, Calif.-based medical device developer that treats asthma, formally withdrew its IPO filing. It had announced last month that it would instead pursue “alternative strategic option,” while the withdrawal filing blames “current market conditions” for its decision. The company has raised venture funding from Boston Scientific Corp., HBM Partners, MedVenture Associates, […]
Scott Kapnick plans to step down as one of Goldman Sachs' three co-heads of investment banking, as first reported by Reuters.
Alimera Sciences Inc., a San Diego-based ophthalmic pharmaceutical company, has completed the $15.9 million second-tranche of its Series B round. The initial $15.9 million tranche was called down in November 2005, with backers on both deals including BA Venture Partners, Domain Associates, Intersouth Partners, Polaris Venture Partners and Venrock Associates. www.alimerasciences.com